The immuno-oncological challenge of COVID-19

L Derosa, C Melenotte, F Griscelli, B Gachot… - Nature Cancer, 2020 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) and its causative virus, SARS-CoV-2, pose
considerable challenges for the management of oncology patients. COVID-19 presents as a …

Hypertension and prohypertensive antineoplastic therapies in cancer patients

DCH Van Dorst, SJH Dobbin, KB Neves… - Circulation …, 2021 - Am Heart Assoc
The development of a wide range of novel antineoplastic therapies has improved the
prognosis for patients with a wide range of malignancies, which has increased the number …

Cardio-oncology: a myriad of relationships between cardiovascular disease and cancer

Y Wang, Y Wang, X Han, J Sun, C Li… - Frontiers in …, 2022 - frontiersin.org
Cardiovascular disease (CVD) and cancer are the leading causes of death worldwide. With
an increasing number of the elderly population, and early cancer screening and treatment …

Screening for Coronary Artery Disease in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review

R Velusamy, M Nolan, A Murphy, P Thavendiranathan… - Cardio Oncology, 2023 - jacc.org
Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in
cancer survivors. This review identifies features that could help guide decisions about the …

Brazilian Cardio-oncology Guideline–2020

LA Hajjar, IBSS Costa, MACQ Lopes… - Arquivos Brasileiros …, 2020 - SciELO Brasil
SciELO - Brasil - Diretriz Brasileira de Cardio-oncologia – 2020 Diretriz Brasileira de Cardio-oncologia
– 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos Lista temática de …

The role of miRNAs in regulation of platelet activity and related diseases-a bioinformatic analysis

Z Wicik, P Czajka, C Eyileten, A Fitas, M Wolska… - Platelets, 2022 - Taylor & Francis
MicroRNAs (miRNAs) are small, non-coding RNAs, able to regulate cellular functions by
induction of mRNA degradation and post-transcriptional repression of gene expression …

Association of hypertension and organ-specific cancer: a meta-analysis

M Connaughton, M Dabagh - Healthcare, 2022 - mdpi.com
Hypertension and cancer are two of the leading global causes of death. Hypertension,
known as chronic high blood pressure, affects approximately 45% of the American …

[HTML][HTML] Diretriz Brasileira de Cardio-oncologia–2020

LA Hajjar, IBSS Costa, MACQ Lopes… - Arquivos Brasileiros …, 2020 - SciELO Brasil
Diretriz Brasileira de Cardio-oncologia–2020 O relatório abaixo lista as declarações de
interesse conforme relatadas à SBC pelos especialistas durante o período de …

New tricks of old drugs: Repurposing non-chemo drugs and dietary phytochemicals as adjuvants in anti-tumor therapies

M Zhang, X Chen, N Radacsi - Journal of Controlled Release, 2021 - Elsevier
Combination therapy has long been applied to enhance therapeutic effect and deal with the
occurrence of multi-drug resistance in cancer treatment. However, the overlapping toxicity of …

Etiology and management of hypertension in patients with cancer

T Mohammed, M Singh, JG Tiu, AS Kim - Cardio-Oncology, 2021 - Springer
The pathophysiology of hypertension and cancer are intertwined. Hypertension has been
associated with an increased likelihood of developing certain cancers and with higher …